Royal Brompton Hospital is situated in Chelsea, right in the heart of London. The area is well served by the London Underground and bus routes and is close to the amenities of London.
Heart and lung expertise
The hospital has more than 1,600 staff, five operating theatres and four catheter laboratories. We have 295 beds, including 48 for surgery, 93 for respiratory patients, 48 for cardiology, 34 paediatric, 20 for intensive care and 16 for paediatric intensive care.
We have an international reputation for the treatment of lung disease, the result of over 160 years’ experience. We are also a national and international leader in the treatment of heart conditions, with large research trials leading to significant developments in the area.
Our hospital is home to Europe's largest centre for the treatment and management of cystic fibrosis and we see patients suffering from asthma and chronic lung conditions including chronic obstructive pulmonary disease (COPD) from across the country.
Our adult congenital heart disease unit was the first of its kind in Europe and remains the largest.
Our leadership in both these fields allows us to attract the best staff from across the world. Our consultants work and teach internationally and publish research papers that set national and international medical standards.
Should they need it, our patients are supported by our dedicated adult and paediatric intensive care units. The hospital has seven dedicated adult critical care consultants and one of the country's largest academic research programmes in intensive care medicine. We are also one of the few hospitals in the country to have a professor of intensive care medicine.
We have invested significantly in the latest imaging technology, which enables us to diagnose patients without invasive procedures in many cases. We acquired the UK’s first ever dedicated cardiac CT scanner in 2005, which means we can diagnose coronary disease at an earlier stage than ever before. We are the largest cardiac magnetic resonance centre in the world and over 50 per cent of the UK’s cardiovascular magnetic resonance scanning (high-definition scans of the heart) are undertaken at our hospital.
Our research into heart and lung conditions is driven by the needs of our patients and is aimed at developing more efficient and effective treatments. Our principal research partner is the National Heart and Lung Institute at Imperial College, London.